无法进行体外受精者接受最多八个卵巢刺激宫腔内人工授精治疗周期的临床妊娠评估
回顾性队列纳入2002至2019年一家大型生育诊所37565个连续卵巢刺激宫腔内人工授精周期,排除无排卵、输卵管因素、男性因素、供精、取消周期及数据缺失者后,经广义估计方程调整年龄、刺激方案和体重指数,显示最多连续8个周期临床妊娠率令人满意。
要点
- 连续8个卵巢刺激宫腔内人工授精周期的临床妊娠率令人满意。
- 调整后第1至8周期每周期平均预测临床妊娠概率为15.7%。
- 第5至8周期平均预测临床妊娠概率与第1周期相比无显著差异。
核心结论
- 最多连续8个卵巢刺激宫腔内人工授精治疗周期的临床妊娠率令人满意。
- 这些数据可用于咨询,尤其适用于因经济或伦理原因无法进行体外受精的患者。
研究设计与样本
- 回顾性队列研究,纳入一家大型生育诊所2002年至2019年的37565个连续卵巢刺激宫腔内人工授精周期,来自18509例患者。
- 排除无排卵诊断、输卵管因素不孕、男性因素不孕、使用供精、取消周期以及基线特征或结局数据缺失者。
- 采用广义估计方程分析临床妊娠率,并控制年龄、刺激方案和体重指数。
主要发现
- 患者年龄小于35岁者占队列的47.6%。
- 调整混杂因素后,第1至8周期的平均预测临床妊娠概率为每周期15.7%。
- 第2至4周期汇总数据的平均预测临床妊娠概率较第1周期(参照)仅低1.7%(16.7% vs. 15.0%,95%CI 第2周期:0.88 {0.82, 0.95},第3周期:0.86 {0.79, 0.93},第4周期:0.88 {0.79, 0.98})。
- 第2至4周期的平均预测临床妊娠概率15.0%与所有纳入周期的均值15.7%一致。
- 第5至8周期的平均预测临床妊娠概率与参照相比无显著差异(16.7% vs. 16.1%,95%CI 第5周期:0.97 [0.85, 1.11],第6周期:0.93 [0.79, 1.10],第7周期:1.01 [0.81, 1.26],第8周期:1.01 [0.76, 1.34])。
关键数值与推荐
- 临床妊娠定义为超声可见胎心的宫内妊娠。
临床怎么用
- 这些数据可用于咨询,尤其适用于因经济或伦理原因无法进行体外受精的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the primary objective of clinical pregnancy (CP) rate per ovarian stimulation with intrauterine insemination (OS-IUI) treatment cycle in patients with repetitive cycles up to a maximum of 8 cycles. DESIGN: Retrospective cohort. SETTING: Large fertility clinic. PATIENTS: A total of 37,565 consecutive OS-IUI cycles from 18,509 patients were included in this study. INTERVENTIONS: Those with anovulatory diagnoses, tubal factor infertility, male factor infertility, using donor sperm, canceled cycles, and those with missing data for either baseline characteristics or outcome were excluded. The CP rate was analyzed using generalized estimating equations and controlled for age, stimulation protocol, and body mass index. MAIN OUTCOMES MEASURES: Clinical pregnancy was defined as intrauterine gestation with fetal heartbeat visible on ultrasound. RESULTS: A total of 37,565 consecutive OS-IUI cycles from 2002 through 2019 at a private practice facility were evaluated. All cycles met inclusion criteria and were used in generalized estimating equation modeling. Patients aged <35 years comprised 47.6% of the cohort. After adjustment for confounders, the mean predicted probability of CP for cycles one to 8 was 15.7% per cycle. The mean predicted probability of CP in aggregated data from cycles 2 to 4 was only 1.7% lower compared with cycle 1 as the referent (16.7% vs. 15.0%, 95% confidence interval [CI] 2nd: 0.88 {0.82, 0.95}, 3rd: 0.86 {0.79, 0.93}, 4th: 0.88 {0.79, 0.98}). However, the 15.0% mean predicted probability of CP for the second through the fourth cycle was concordant with the mean for all included cycles (15.7%). The mean predicted probability of CP of cycles 5 to 8 was not significantly different compared with the referent (16.7% vs. 16.1%, 95% CI 5th: 0.97 [0.85, 1.11], 6th: 0.93 [0.79, 1.10], 7th: 1.01 [0.81, 1.26], 8th: 1.01 [0.76, 1.34]). The modeling of consecutive cycles suggested that the adjusted cumulative predicted probability of CP from OS-IUI continues to increase with each of the 8 successive cycles. CONCLUSION: Clinical pregnancy rates are satisfactory in up to 8 consecutive OS-IUI treatment cycles. These data are useful for counseling, especially in those patients for whom in vitro fertilization is not financially or ethically feasible.
引用
- Evans MB, Hosseinzadeh P, Flannagan K, et al. Assessment of clinical pregnancies in up to eight ovarian stimulation with intrauterine insemination treatment cycles in those unable to proceed with in vitro fertilization. Fertil Steril. 2024. PMID: 38365110. doi:10.1016/j.fertnstert.2024.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。